摘要:
The invention relates to the use of copolymers comprising a) 82 to 99.9 mol % of at least one monoethylenically unsaturated C3-C8-carboxylic acid; b) 0.1 to 18 mol % of at least one monomer selected from the group b1) N—C8-C30-alkyl-substituted amides of monoethylenically unsaturated C3-C8-carboxylic acids, b2) N,N—C8-C30-dialkyl-substituted amides of monoethylenically unsaturated C3-C8-carboxylic acids, b3) C8-C30-alkyl esters of monoethylenically unsaturated C3-C8-carboxylic acids; c) 0 to 17.9 mol % of at least one monomer selected from the group of c1) vinyl esters of aliphatic C8-C30-carboxylic acids, c2) C8-C30-alkylvinyl ethers, mol % data for the individual components adding up to 100%, as solubilizer.
摘要:
The invention relates to the use of copolymers comprising a) 82 to 99.9 mol % of at least one monoethylenically unsaturated C3-C8-carboxylic acid; b) 0.1 to 18 mol % of at least one monomer selected from the group b1) N—C8-C30-alkyl-substituted amides of monoethylenically unsaturated C3-C8-carboxylic acids, b2) N,N—C8-C30-dialkyl-substituted amides of monoethylenically unsaturated C3-C8-carboxylic acids, b3) C8-C30-alkyl esters of monoethylenically unsaturated C3-C8-carboxylic acids; c) 0 to 17.9 mol % of at least one monomer selected from the group of c1) vinyl esters of aliphatic C8-C30-carboxylic acids, c2) C8-C30-alkylvinyl ethers, the mol % data for the individual components adding up to 100%, as solubilizer.
摘要:
The use of copolymers ofA) 60-99 mol % of N-vinylpyrrolidone, andB) 1-40 mol % of a monomer selected from the group ofb1) C.sub.8 -C.sub.30 -alkyl esters of monoethylenically unsaturated C.sub.3 -C.sub.8 -carboxylic acids,b2) N-alkyl- or N,N-dialkyl-substituted amides of acrylic acid or of methacrylic acid with C.sub.8 -C.sub.18 -alkyl radicals, orb3) vinyl esters of aliphatic C.sub.8 -C.sub.30 -carboxylic acids, or mixtures of these monomers,as surface-active substances in preparations of water-insoluble substances.
摘要:
Insoluble, only slightly swellable popcorn polymers containing a) from 50 to 99% by weight of styrene and/or at least one monounsaturated styrene derivative, b) from 0.1 to 40% by weight of at least one N-vinyllactam or N-vinylamine and c) from 0.1 to 10% by weight of at least one difunctional crosslinking component, the stated percentages by weight of the individual components a) to c) summing to 100%.
摘要:
Solid dosage forms are obtained by mixing at least one polymeric binder, at least one active ingredient, and, where appropriate, conventional additives to form a plastic mixture, and shaping, using as polymeric binder a copolymer of an N-vinyllactam and a copolymerizable monomer having a hydrophobic radical. Dosage forms which show slow release of the active ingredient are obtained in a simple and low-cost manner.
摘要:
The use of copolymers comprising a) 50 to 99% by weight of at least one N-vinyllactam or N-vinylamine selected from the group consisting of N-vinylpyrrolidone, N-vinylpiperidone, N-vinylcaprolactam, N-vinylimidazole and methylated N-vinylimidazole or N-vinylformamide and b) 1 to 50% by weight of at least one monomer selected from the group of b1) C14-C30-alkyl esters of monoethylenically unsaturated C3-C8-carboxylic acids; b2) N—C8-C30-alkyl-substituted amides of monoethylenically unsaturated C3-C8-carboxylic acids; b3) N,N—C8-C30-dialkyl-substituted amides of monoethylenically unsaturated C3-C8-carboxylic acids; b4) vinyl esters of aliphatic C8-C30-carboxylic acids; b5) C8-C30-alkyl vinyl ethers as matrix for producing solid pharmaceutical and cosmetic presentations.
摘要:
The use of graft copolymers obtainable by grafting a) polyalkylene oxides with b) at least one monomer selected from the group of b1) C1-C30-alkyl esters of monoethylenically unsaturated C3-C8-carboxylic acids; b2) vinyl esters of aliphatic C1-C30-carboxylic acids; b3) C1-C30-alkyl vinyl ethers; b4) N—C1-C12-alkyl-substituted amides of monoethylenically unsaturated C3-C8-carboxylic acids; b5) N,N—C1-C12-dialkyl-substituted amides of monoethylenically unsaturated C3-C8-carboxylic acids as solubilizer.
摘要:
The present invention relates to a solid dosage form comprising at least one polymeric binder and at least one active ingredient and, where appropriate, conventional additives, wherein the polymeric binder consists of copolymerized units a) 15-83% by weight of at least one N-vinyllactam, b) 15-83% by weight of methyl methacrylate, c) 2-70% by weight of at least one other monomer and d) 0-9.9% by weight of at least one &agr;,&bgr;-ethylenically unsaturated acid.
摘要:
The use is described of particulate, water-insoluble and scarcely swellable polymers of ethylenically unsaturated monomers, which polymers contain, copolymerized, at least 20% by weight, based on the total weight of the monomers, of at least one &agr;,&bgr;-monoethylenically unsaturated monocarboxylic acid having from 3 to 6 carbons as filter aid for filtering aqueous liquids. Subject-matter of the invention are also water-insoluble, scarcely swellable polymers (popcorn polymers) that contain, copolymerized, &agr;,&bgr;-monoethylenically unsaturated carboxylic acids and styrene or styrene derivatives, and also a process for their preparation.
摘要:
Compositions comprising at least one water-insoluble ingredient and at least one copolymer of A) from 5 to 99% by weight of at least one N-vinylcarboxamide of the formula I where R1 and R2 independently of one another are hydrogen or C1-C6-alkyl; B) from 1 to 95% by weight of at least one monomer having a hydrophobic radical which can be copolymerized with vinylcarboxamides of the formula I; and optionally C) from 0 to 94% by weight of at least one other copolymerizable monomer, and the use of the above copolymers as solubility promoters.